PE-Labeled Human HLA-A*02:01&B2M&p53 (HMTEVVRHC) Tetramer Protein
TP53 has been recognized as a tumor suppressor. 50% of cancers carry a TP53 mutation while many others affect other pathway components. High-copy numbers of WT p53 peptide-MHC class I complexes were detected on tumor cells as compared to low copies on normal cells. The Human HLA-A*0201 p53 (HMTEVVRHC) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and HMTEVVRHC peptide of the p53.
Product Specifications
Background
Specifications
Expression Region
Ile 21 - Met 119 (B2M) & Gly 25 - Ile 308 (HLA-A*02:01) & HMTEVVRHC peptide
Target
HLA-A*0201 & B2M & p53 (HMTEVVRHC)
Conjugation
PE Labeled
Tag
C-10xHis
Stability
Format
Powder
Buffer
PBS, 1% BSA, pH7.4
Molecular Weight
49.3 kDa
Additionnal Information
Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments
Shipping Conditions
RT
Storage Conditions
-20°C, avoid light
Package Size
100ug*2
Host or Source
HEK293
Species
Human
Protein ID
P61769-1 (B2M) & AAA59606.1 (HLA-A*02:01) & HMTEVVRHC
Preservative
Trehalose
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF405S conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF405M conjugate, 0.1mg/mL
CD59 (heavy chain of Protectin) (BRA-10G), CF405S conjugate, 0.1mg/mL
MAGE A1 (MA454), CF640R conjugate, 0.1mg/mL
